Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Reports Second Quarter 2013 Results

Marketwired August 7, 2013

Insulet Corporation to Present at the Canaccord Genuity 33rd Annual Growth Conference

Marketwired July 31, 2013

Insulet Corporation to Report Second Quarter 2013 Financial Results on August 7, 2013

Marketwired July 23, 2013

Insulet Corporation to Present at the 8th Annual JMP Securities Healthcare Conference

Marketwired June 27, 2013

John Garibotto Joins Cellnovo's Board of Directors

PR Newswire June 21, 2013

Invitations to Investors Conferences and Annual Report Filings - Research Report on Haemonetics, Insulet, DexCom, HeartWare, and Mindray

PR Newswire June 11, 2013

Insulet Corporation to Present at Upcoming Investor Conferences

Marketwired May 15, 2013

Insulet Corporation is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Newsfile May 8, 2013

Insulet Reports First Quarter 2013 Results

Marketwired May 6, 2013

Insulet to Develop New Version of the OmniPod Insulin Pump for Use With Humulin R U-500 Concentrated Insulin for People With Type 2 Diabetes

Marketwired May 2, 2013

Insulet Corporation to Report First Quarter 2013 Financial Results on May 6, 2013

Marketwired April 23, 2013

Insulet Reports Fourth Quarter and Full Year 2012 Results

Marketwired February 27, 2013

Insulet Corporation to Present at the Raymond James 34th Annual Institutional Investors Conference

Marketwired February 26, 2013

Insulet Corporation to Report Fourth Quarter and Full Year 2012 Financial Results on February 27, 2013

Marketwired February 7, 2013

Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference

Marketwired February 6, 2013

Insulet Appoints Tracey H. Wielinski as VP, Global Regulatory/Clinical Affairs and Quality Assurance

Marketwired January 23, 2013

Insulet Corporation Announces the Sale of $85 Million of Common Stock

Marketwired January 3, 2013

Insulet Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference

Marketwired January 2, 2013

Stockhouse @ the Bell: Stocks get Alcoa lift

Stockhouse Editorial April 11, 2012